Hepatoprotective effect of forsythiaside a against acetaminophen-induced liver injury in zebrafish : Coupling network pharmacology with biochemical pharmacology

Copyright © 2021 Elsevier B.V. All rights reserved..

ETHNOPHARMACOLOGICAL RELEVANCE: Forsythiae Fructus, the dried fruit of Forsythia suspensa (Thunb.) Vahl, is a commonly used traditional Chinese medicine and possesses various pharmacological activities, including anti-inflammation, anti-oxidant and liver protection.

AIM OF THE STUDY: Although acetaminophen (APAP) has been frequently used for its antipyretic and analgesic effects, it leads to liver injury at an overdose or long-term medication. Forsythiaside A (FA), the principal active component of Forsythiae Fructus, exerts prominent antioxidant, anti-inflammatory and hepatoprotective effects. However, the protective property and underlying mechanism of FA against APAP challenge have not yet been elucidated. Therefore, we aimed to explore the hepatoprotective effect and action mechanism of FA against APAP-induced liver injury in zebrafish.

MATERIALS AND METHODS: In this study, liver-specific transgenic zebrafish larvae (lfabp: EGFP) were used to investigate the protective effect of FA against overdose APAP exposure. The liver phenotype, morphological and biochemical assessments were carried out to evaluate the hepatoprotective effect of FA. Network pharmacology and molecular docking study were conducted to analyze the potential targets of FA in the treatment of APAP-induced liver injury. Finally, the mechanism of action was verified by reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR).

RESULTS: The liver phenotype, morphological and biochemical assessments indicated that FA could mitigate APAP-triggered liver injury. Network pharmacology and molecular docking analysis indicated that the protective effect of FA might be related to the regulation of targets tumor necrosis factor (TNF), matrix metallopeptidase 9 (MMP9), matrix metallopeptidase 2 (MMP2), and phosphatidylinositol 3-kinase (PI3K). PCR results confirmed that FA could reverse the progressive alterations of genes involving in extracellular matrix remolding and PI3K/AKT-mediated apoptosis signaling pathway.

CONCLUSIONS: Our results indicated that FA could mitigate APAP-induced liver injury through modulating the remolding of extracellular matrix and PI3K/AKT-mediated apoptosis.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:271

Enthalten in:

Journal of ethnopharmacology - 271(2021) vom: 10. Mai, Seite 113890

Sprache:

Englisch

Beteiligte Personen:

Gong, Lihong [VerfasserIn]
Zhou, Honglin [VerfasserIn]
Wang, Cheng [VerfasserIn]
He, Linfeng [VerfasserIn]
Guo, Chaocheng [VerfasserIn]
Peng, Cheng [VerfasserIn]
Li, Yunxia [VerfasserIn]

Links:

Volltext

Themen:

362O9ITL9D
Acetaminophen
Alanine Transaminase
Aspartate Aminotransferases
EC 2.6.1.1
EC 2.6.1.2
EC 2.7.11.1
Forsythiaside
Forsythiaside A
GAN16C9B8O
Glutathione
Glycosides
Hepatoprotection
Journal Article
Liver injury
Network pharmacology
OUH5BQ893P
Protective Agents
Proto-Oncogene Proteins c-akt

Anmerkungen:

Date Completed 15.09.2021

Date Revised 15.09.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jep.2021.113890

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM320782433